Cryo Cell International Inc Revenue Growth Rates (CCEL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cryo cell International Inc   (NYSEAMER: CCEL)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CCEL's Revenue Growth by Quarter and Year

Cryo Cell International Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CCEL/growth
https://api.csimarket.com/api/v1/companies/CCEL/fundamentals
https://api.csimarket.com/api/v1/companies/CCEL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
CCEL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter November -
3rd Quarter August 7.82
2nd Quarter May 7.78
1st Quarter February 7.68
FY 23.28

CCELs Annual Revenue
Cryo Cell International Inc 's Revenue in the fiscal year 2025 $ 31.57 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2024 $ 31.99 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2023 $ 31.34 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2022 $ 30.34 millions
Cryo Cell International Inc 's Revenue in the fiscal year 2021 $ 28.88 millions




CCEL Revenue third quarter 2026 Y/Y Growth Comment
Cryo Cell International Inc reported decrease in Revenue in the third quarter 2026 by -0.07% to $ 7.82 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Cryo Cell International Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 4.25%.

Looking into third quarter 2026 results within Healthcare Facilities industry 27 other companies have achieved higher Revenue growth. While Cryo Cell International Inc ' s Revenue decline of -0.07% ranks overall at the positon no. 2698 in the third quarter 2026.


CCEL Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter November -
3rd Quarter August -0.07 %
2nd Quarter May -1.89 %
1st Quarter February -3.64 %
FY   -

Financial Statements
Cryo Cell International Inc 's third quarter 2026 Revenue $ 7.82 millions CCEL's Income Statement
Cryo Cell International Inc 's third quarter 2025 Revenue $ 7.83 millions Quarterly CCEL's Income Statement


CCEL Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter November -
3rd Quarter August 0.57 %
2nd Quarter May 1.3 %
1st Quarter February -2.04 %
FY (Year on Year)   -


Back to CCEL Growth rate Comparisons >> Back to CCEL Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #28
Healthcare Sector #384
Overall #2698

Revenue Y/Y Growth Statistics
High Average Low
22.83 % 4.25 % -7.81 %
(May 31 2019)   (Aug 31 2021)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #28
Healthcare Sector #384
Overall #2698
Revenue Y/Y Growth Statistics
High Average Low
22.83 % 4.25 % -7.81 %
(May 31 2019)   (Aug 31 2021)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Cryo Cell International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20.62 % 1.08 % -12.78 %
(Aug 31 2018)  


CCEL's III. Quarter Q/Q Revenue Comment
Cryo cell International Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.57% quarter on quarter, to $ 7.82 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the -1.26% growth in the III. Quarter a year ago

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Cryo Cell International Inc 's Revenue growth quarter on quarter, overall rank is 1718.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #227
Overall #1718
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #227
Overall #1718
Revenue Q/Q Growth Statistics
High Average Low
20.62 % 1.08 % -12.78 %
(Aug 31 2018)  


CCEL's III. Quarter Q/Q Revenue Comment
Cryo cell International Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.57% quarter on quarter, to $ 7.82 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -1.26% in the III. Quarter a year ago.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Cryo Cell International Inc 's Revenue growth quarter on quarter, overall rank is 1718.


Cryo Cell International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Aug 31 2026)		 12 Months Ending (May 31 2026) 12 Months Ending (Feb 28 2026) 12 Months Ending (Nov 30 2025) 12 Months Ending (Aug 31 2025)
Cumulative Revenue 12 Months Ending $ 31.13
Y / Y Revenue Growth (TTM) -1.96 %
Year on Year Revenue Growth Overall Ranking # 2662
Seqeuential Revenue Change (TTM) -0 %
Seq. Revenue Growth (TTM) Overall Ranking # 2698


Cumulative Revenue growth Comment
Cryo Cell International Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in May 31 2026. If the fiscal year would end in Aug 31 2026, Cryo Cell International Inc 's annual Revenue no change would be -1.96% year on year to $31 millions.

In the Healthcare sector 378 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2537 to 2662.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 379
Overall # 2662

Revenue TTM Y/Y Growth Statistics
High Average Low
22.83 %
 4.25 %
-7.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 384
S&P 500 # 2698
Cumulative Revenue growth Comment
Cryo Cell International Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in May 31 2026. If the fiscal year would end in Aug 31 2026, Cryo Cell International Inc 's annual Revenue decrease would be -1.96% year on year to $31 millions.

In the Healthcare sector 378 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2537 to 2662.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 379
Overall # 2662

Revenue TTM Y/Y Growth Statistics
High Average Low
22.83 %
4.25 %
-7.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 384
S&P 500 # 2698




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CCEL's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Aug 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Aug 31 2026
Cryo cell International Inc -0.02%$ -0.016 millions
Medinotec Inc -1.10%$ -1.103 millions
Biomerica Inc -8.33%$ -8.333 millions


About Cryo Cell International Inc Revenue Growth Rates (CCEL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cryo Cell International Inc (CIK 862692).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-419156
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cryo Cell International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.